To study the therapeutic potential of KIN-8194 for MCL treatment, we assessed its effect on cell growth, in comparison with clinically applied BTK inhibitors (BTKi), in a panel of MCL cell lines. This evidence concerns the gene BTK and mantle cell lymphoma.